P. Twentyman

发表

Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.

P. Charlton, I. Dale, R. Callaghan, 1998, British Journal of Cancer.

Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.

P. Workman, H. Coley, W. Amos, 1993, British Journal of Cancer.

Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A

N. Bleehen, P. Twentyman, 1991 .

Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin [corrected].

N. Bleehen, P. Twentyman, 1991, European journal of cancer.

Timing of assays: an important consideration in the determination of clonogenic cell survival both in vitro and in vivo.

P. Twentyman, 1979, International journal of radiation oncology, biology, physics.

The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.

N. Bleehen, P. Twentyman, 1976, British Journal of Cancer.

Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.

N. Bleehen, P. Twentyman, 1975, British Journal of Cancer.

Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo.

N. Bleehen, P. Twentyman, 1975, British Journal of Cancer.

Changes in sensitivity to radiation and to blemycin occurring during the life history of monolayer cultures of a mouse tumour cell line.

N. Bleehen, P. Twentyman, 1975, British Journal of Cancer.

CHANGES IN CELL PROLIFERATION KINETICS OCCURRING DURING THE LIFE HISTORY OF MONOLAYER CULTURES OF A MOUSE TUMOUR CELL LINE

N. Bleehen, N. Bleehen, J. Watson, 1975, Cell and tissue kinetics.

The sensitivity to bleomycin of a solid mouse tumour at different stages of growth.

N. Bleehen, P. Twentyman, 1974, British Journal of Cancer.

The Sensitivity of Cells in Exponential and Stationary Phases of Growth to Bleomycin and to 1,3-bis(2-chloroethyl)-1-Nitrosourea

N. Bleehen, P. Twentyman, 1973, British Journal of Cancer.

A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity.

M. Luscombe, P. Twentyman, P. Twentyman, 1987, British Journal of Cancer.

Bleomycin--mode of action with particular reference to the cell cycle.

P. Twentyman, 1983, Pharmacology & therapeutics.

Effects of changes in oxygen tension, pH, and glucose concentration on the response to CCNU of EMT6 mouse tumor monolayer cells and multicellular spheroids.

T. Kwok, P. Twentyman, 1988, International journal of radiation oncology, biology, physics.

Spheroids for studies of drug effects.

P. Twentyman, T. Nederman, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.

P. Twentyman, T. Rhodes, 1992, British Journal of Cancer.

Response to X-radiation and cytotoxic drugs of clonal subpopulations of different ploidy and metastatic potential isolated from RIF-1 mouse sarcoma.

P. Twentyman, J. G. Reeve, K. Wright, 1983, British Journal of Cancer.

Clonal variation in the arrest, survival and growth of RIF-1 mouse sarcoma cells in the lungs of C3H mice.

P. Twentyman, J. G. Reeve, 1983, British Journal of Cancer.

Ploidy distribution of tumour cells derived from induced and spontaneously arising metastases of a murine radiation-induced sarcoma, RIF-1.

P. Twentyman, J. G. Reeve, 1982, European journal of cancer & clinical oncology.

Chemosensitization by lipophilic nitroimidazoles.

P. Workman, P. Twentyman, 1983, British Journal of Cancer.

Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.

P. Workman, P. Twentyman, 1982, British Journal of Cancer.

A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene.

M. Barrand, P. Rabbitts, P. Twentyman, 1994, Journal of the National Cancer Institute.

MODIFIERS OF MULTIDRUG RESISTANCE

P. Twentyman, 1995, British journal of haematology.

Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.

P. Workman, H. Coley, P. Twentyman, 1991, British Journal of Cancer.

Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69.

P. Rabbitts, P. Twentyman, J. G. Reeve, 1989, British Journal of Cancer.

Evidence that multidrug resistance in Chinese hamster ovary cells is associated with alterations in the endoplasmic reticulum.

G. Koch, P. Twentyman, J. G. Reeve, 1987, British Journal of Cancer.

Identification of a novel calcium‐binding protein (CP22) in multidrug‐resistant murine and hamster cells

P. Twentyman, G. Koch, K. Wright, 1986, FEBS letters.

Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.

N. Bleehen, N. Fox, P. Twentyman, 1986, British Journal of Cancer.

Drug resistance in human lung cancer cell lines: cross-resistance studies and effects of the calcium transport blocker, verapamil.

N. Bleehen, N. Fox, P. Twentyman, 1986, International journal of radiation oncology, biology, physics.

Resistance in Patients ' Tumors : Consensus Recommendations Methods to Detect P-Glycoprotein-associated Multidrug Updated

William, Catherine, Nathalie, 2006 .

Characterisation of a mouse tumour cell line with in vitro derived resistance to verapamil.

N. Fox, P. Twentyman, K. Wright, 1990, British Journal of Cancer.

Radiation response of human lung cancer cells with inherent and acquired resistance to cisplatin.

P. Twentyman, T. Rhodes, K. Wright, 1991, International journal of radiation oncology, biology, physics.

Small cell lung cancer cell lines secrete predominantly ACTH precursor peptides not ACTH.

M. F. Stewart, A. White, P. Twentyman, 1989, British Journal of Cancer.

Chapter 13 Identification of antigenic phenotypes characterising lung tumour cell lines in vitro

N. Bleehen, P. Twentyman, J. Shaw, 1988 .

The influence of glutathione metabolism on multidrug resistance in MRP-overexpressing cells.

P. Twentyman, T. Bagrij, 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Localisation of the multidrug resistance-associated protein, MRP, in resistant large-cell lung tumour cells.

M. Barrand, S. Neo, R. Scheper, 1995, Biochemical pharmacology.

A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.

P. Twentyman, T. Rhodes, S. Rayner, 1994, European journal of cancer.

Non-P-glycoprotein-mediated multidrug resistance with reduced EGF receptor expression in a human large cell lung cancer cell line.

P. Rabbitts, P. Twentyman, J. G. Reeve, 1990, British Journal of Cancer.

Neuron specific enolase expression in carcinoma of the lung.

N. Bleehen, J. Stewart, P. Twentyman, 1986, British Journal of Cancer.

9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance.

P. Workman, H. Coley, P. Twentyman, 1990, European journal of cancer.

Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.

L. Kèlland, B. Murrer, P. Mistry, 1992, Cancer research.

Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay

N. Fox, P. Twentyman, J. Rees, 1989, British journal of haematology.

Modification of cytotoxic drug resistance by non-immuno-suppressive cyclosporins.

P. Twentyman, 1988, British Journal of Cancer.

The occurrence and toxicity of a red tide caused by Noctiluca scintillans (Macartney) Ehrenb., in the coastal waters of Hong Kong

B. Morton, P. Twentyman, 1971 .

Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line.

N. Fox, P. Twentyman, D. J. White, 1987, British Journal of Cancer.

The in vitro effects and cross-resistance patterns of some novel anthracyclines.

N. Bleehen, P. Workman, N. Fox, 1986, British Journal of Cancer.

The effect of bleomycin and radiation in combination on bacteria and mammalian cells in culture.

N. Bleehen, P. Twentyman, N. Gillies, 1974, The British journal of radiology.

Monoclonal‐antibody‐defined human lung tumour cell‐surface antigens

N. Bleehen, J. Stewart, P. Twentyman, 1985, International journal of cancer.

Identification of anthracyclines and related agents that retain preferential activity over Adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A

P. Workman, H. Coley, P. Twentyman, 2008, Cancer Chemotherapy and Pharmacology.

P. Workman, H. Coley, P. Twentyman, 2004, Cancer Chemotherapy and Pharmacology.

Preclinical pharmacokinetics of benznidazole.

P. Workman, M. Walton, R. White, 1984, British Journal of Cancer.

Inducing remission in drug resistant acute myeloid leukaemia with cyclosporin A

M. Gandhi, P. Twentyman, J. Rees, 2008 .

Predictive chemosensitivity testing.

P. Twentyman, 1985, British Journal of Cancer.

Response to the RIF-1 tumor in vitro and in C3H/Km mice to X-radiation (cell survival, regrowth delay, and tumor control), chemotherapeutic agents, and activated macrophages.

S. Zamvil, J. Brown, P. Twentyman, 1980, Journal of the National Cancer Institute.

The activity of deoxyspergualin in multidrug-resistant cells

J. Holmes, P. Twentyman, 2004, Cancer Chemotherapy and Pharmacology.

The response to cytotoxic drugs of EMT6 cells treated either as intact or disaggregated spheroids.

T. Kwok, P. Twentyman, 1985, British Journal of Cancer.

Modification by WR 2721 of the response to chemotherapy of tumours and normal tissues in the mouse.

P. Twentyman, 1983, British Journal of Cancer.

Modulation by acrolein and chloroacetaldehyde of multidrug resistance mediated by the multidrug resistance-associated protein (MRP).

P. Twentyman, R. G. Manzano, K. Wright, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Experimental chemotherapy studies: intercomparison of assays.

P. Twentyman, 1980, The British journal of cancer. Supplement.

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--II. Cyclophosphamide.

J. Brown, P. Twentyman, R. Kallman, 1979, International journal of radiation oncology, biology, physics.

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. V. Bleomycin.

J. Brown, P. Twentyman, R. Kallman, 1979, International journal of radiation oncology, biology, physics.

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. III. Cis-diamminedichloroplatinum.

J. Brown, P. Twentyman, R. Kallman, 1979, International journal of radiation oncology, biology, physics.

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--I. Adriamycin.

J. Brown, P. Twentyman, R. Kallman, 1979, International journal of radiation oncology, biology, physics.

Position paper by the UKCCCR Elderly Cancer Patients in Clinical Trials Working Group

L. Fallowfield, I. Fentiman, E. Grundy, 1999, British Journal of Cancer.

Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolism.

P. Workman, M. Walton, F. Y. Lee, 1983, Biochemical pharmacology.

Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitro.

H. Wallace, P. Twentyman, K. Wright, 1992, British Journal of Cancer.

Failure of GM-CSF to influence the growth of small cell and non-small cell lung cancer cell lines in vitro.

P. Twentyman, K. Wright, 1991, European journal of cancer.

Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin).

G. Koch, P. Twentyman, J. G. Reeve, 1990, British Journal of Cancer.

The MTT assay underestimates the growth inhibitory effects of interferons.

J. Watson, P. Twentyman, P. R. Twentyman, 1989, British Journal of Cancer.

Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.

P. Workman, H. Coley, P. Twentyman, 1989, Biochemical pharmacology.

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

D. Charnock-Jones, Stephen K. Smith, P. Barker, 1995, Journal of the National Cancer Institute.

Use of a colorimetric microtiter (MTT) assay in determining the radiosensitivity of cells from murine solid tumors.

T. Wasserman, P. Twentyman, 1988, International journal of radiation oncology, biology, physics.

The sensitivity to bleomycin of spleen colony forming units in the mouse.

N. Bleehen, P. Twentyman, 1973, British Journal of Cancer.

Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridisation.

M. Barrand, P. Rabbitts, P. Twentyman, 1994, European journal of cancer.

Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines.

R. Griffin, P. Lambert, P. Twentyman, 1998, Biochemical pharmacology.

Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance.

P. Twentyman, C. Versantvoort, Carolina H. M. Versantvoort, 1996, European journal of cancer.

[Alkaloids in Sophora alopecuroides seed and relevant tests for activity].

P. Twentyman, P. Houghton, L. Zhang, 1997, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

A new mouse tumor model system (RIF-1) for comparison of end-point studies.

J. Gray, P. Twentyman, R. Kallman, 1980, Journal of the National Cancer Institute.

Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines.

N. Saijo, Y. Fujiwara, W. Hong, 1989, International journal of cancer.

Resistance circumvention strategies tested in clinical leukaemia specimens using the MTT colorimetric assay.

P. Twentyman, J. Rees, E. Lambert, 1992, Leukemia.

Action of cytotoxic agents on the erythroid system of the mouse.

P. Twentyman, N. Blackett, 1970, Journal of the National Cancer Institute.

Mechanisms of MRP over‐expression in four human lung‐cancer cell lines and analysis of the MRP amplicon

F. Baas, P. Borst, M. Breuning, 1995, International journal of cancer.

The response of tumour cells to radiation and cytotoxic drugs--a comparison of clonogenic and isotope uptake assays.

P. Twentyman, K. Wright, G. A. Walls, 1984, British Journal of Cancer.

Cytogenetic abnormalities in human small cell lung carcinoma: cell lines characterized for myc gene amplification.

N. Bleehen, P. Rabbitts, J. Waters, 1988, Cancer genetics and cytogenetics.

Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma).

N. Bleehen, P. Workman, N. Fox, 1985, British Journal of Cancer.

Enhancement by hyperthermia of the effect of BCNU against the EMT6 mouse tumor.

P. Twentyman, J. Morgan, J. Donaldson, 1978, Cancer treatment reports.

An unusually proximal deletion on the short arm of chromosome 3 in a patient with small cell lung cancer.

J. Bergh, N. Bleehen, P. Rabbitts, 1991, Genomics.

Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer.

N. Bleehen, R. Osborne, J. Smyth, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serum.

M. Lehnert, R. de Giuli, P. Twentyman, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.

R. González Manzano, P. Twentyman, K. Wright, 1996, European journal of cancer.

Chapter 21 Expression of monoclonal antibody-defined lung tumour antigens in drug resistant lung tumour cell lines

N. Bleehen, P. Twentyman, J. Shaw, 1988 .

The Basic Science of Oncology. 2nd Edition

P. Twentyman, 1993, British Journal of Cancer.

Use of bacterial neutral protease for disaggregation of mouse tumours and multicellular tumor spheroids.

J. Yuhas, P. Twentyman, 1980, Cancer letters.

Comparative chemosensitivity of exponential- versus plateau-phase cells in both in vitro model systems.

P. Twentyman, 1976, Cancer treatment reports.

Hypotonicity-induced anion fluxes in cells expressing the multidrug-resistance-associated protein, MRP

S. Hladky, M. Barrand, A. Hainsworth, 1996, Pflügers Archiv.

Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds.

P. Twentyman, C. Versantvoort, T. Rhodes, 1996, British Journal of Cancer.

Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.

R. Scheper, H. Broxterman, P. Twentyman, 1995, British Journal of Cancer.

The efflux of anthracyclines in multidrug-resistant cell lines.

P. Workman, H. Coley, P. Twentyman, 1993, Biochemical pharmacology.

Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein.

M. Barrand, M. Center, P. Twentyman, 1993, European journal of cancer.

Cyclosporins as drug resistance modifiers.

P. Twentyman, 1992, Biochemical pharmacology.

The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude mice.

N. Bleehen, P. Workman, P. Twentyman, 1985, British Journal of Cancer.

Response to chemotherapy of EMT6 spheroids as measured by growth delay and cell survival.

P. Twentyman, P. R. Twentyman, 1980, British Journal of Cancer.

An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.

P. Workman, P. Twentyman, 1983, British Journal of Cancer.

Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.

P. Workman, P. Twentyman, 1982, British Journal of Cancer.

The effect of cytotoxic drugs with or without misonidazole on leucopenia in three strains of mice.

J. Peacock, N. J. McNally, T. Stephens, 1982, International journal of radiation oncology, biology, physics.

A comparison of clonogenic and radionuclide uptake assays for determining the radiation response of human small-cell lung cancer xenografts and cell lines.

N. Fox, P. Twentyman, 1987, The British journal of radiology.

Growth delay in small EMT6 spheroids induced by cytotoxic drugs and its modification by misonidazole pretreatment under hypoxic conditions.

P. Twentyman, 1982, British Journal of Cancer.

The use of clonogenic assays in assessing the response of human lung cancer cell lines to α and γ interferons alone or in combination with adriamycin

P. Twentyman, S. Jabbar, 1990 .

Flow cytometric analysis of Hoechst 33342 uptake as an indicator of multi-drug resistance in human lung cancer.

P. Smith, J. Watson, P. Twentyman, 1989, British Journal of Cancer.

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. VI. BCNU.

P. Twentyman, R. Kallman, P. Lelieveld, 1979, International journal of radiation oncology, biology, physics.

In vitro pre-incubation with misonidazole under hypoxic conditions--effect on drug response of EMT6 spheroids.

P. Twentyman, 1982, International journal of radiation oncology, biology, physics.

Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: structure-activity relationships.

P. Workman, P. Twentyman, 1982, International journal of radiation oncology, biology, physics.

Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.

P. Twentyman, 1981, British Journal of Cancer.

Sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea of the EMT6 tumor in vivo as determined by both tumor volume response and in vitro plating assay.

P. Twentyman, 1978, Cancer research.

Flowcytometric analysis ofHoechst 33342uptake asanindicator of multi-drug resistance inhumanlungcancer

J. Watson, P. Twentyman, S. Morgan, 1989 .

The effect of pre- or post-treatment with a calmodulin inhibitor (trifluoperazine) on the response to cytotoxic agents of cells within small EMT6/Ca/VJAC spheroids.

T. Kwok, P. Twentyman, 1986, International journal of radiation oncology, biology, physics.

Third International Conference on Spheroids in Cancer Research

P. Twentyman, 1987 .

The way ahead

P. Twentyman, P. Selby, 1991, British Journal of Cancer.

Pro-opiomelanocortin gene expression and peptide secretion in human small-cell lung cancer cell lines.

M. F. Stewart, W. Farrell, A. Clark, 1989, Journal of molecular endocrinology.

Radiation Response of Tumours: Experimental

P. Twentyman, 1988 .

Reduced nuclear binding of a DNA minor groove ligand (Hoechst 33342) and its impact on cytotoxicity in drug resistant murine cell lines.

P. Smith, J. Watson, P. Twentyman, 1990, British Journal of Cancer.

Differential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodies.

M. Barrand, P. Twentyman, 1992, British Journal of Cancer.

Collateral resistance to verapamil in multidrug-resistant mouse tumor cells.

P. Rabbitts, G. Koch, P. Twentyman, 1989, Journal of the National Cancer Institute.

A possible role for cyclosporins in cancer chemotherapy.

P. Twentyman, 1988, Anticancer research.

Studies of the cavitational effects of clinical ultrasound by sonoluminescence.

P P Dendy, T G Leighton, P. Dendy, 1988 .

CB 1954 revisited

P. Workman, P. Twentyman, J. Morgan, 2004, Cancer Chemotherapy and Pharmacology.

MDR1 (P-glycoprotein) gene expression--implications for resistance modifier trials.

P. Twentyman, 1992, Journal of the National Cancer Institute.

The Effects of Repeated. Doses of Bacterial Endotoxin on Erythropoiesis in the Normal and Splenectomized Mouse

P. Twentyman, 1972, British journal of haematology.

Chemosensitisation of a drug-sensitive parental cell line by low-dose cyclosporin A

P. Twentyman, K. Wright, 2004, Cancer Chemotherapy and Pharmacology.

The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs — An in vitro study using EMT6 multicellular spheroids

T. Kwok, P. Twentyman, 1985, International journal of cancer.

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. IV. Actinomycin-D.

P. Twentyman, R. Kallman, J. Brown, 1979, International journal of radiation oncology, biology, physics.

Red cell production in the mouse following treatment with vinblastine.

P. Twentyman, N. Blackett, 1971, Blood.

Leucocyte Response to Bacterial Endotoxin in Mice Pre‐treated with Cytotoxic Agents

P. Twentyman, 1972, British journal of haematology.

Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistance.

P. Workman, H. Coley, P. Twentyman, 1992, Anti-cancer drug design.

Establishment and characterization of cisplatin‐resistant sublines of human lung cancer cell lines

N. Saijo, W. Hong, Y. Sasaki, 1988, International journal of cancer.

On the relationship between the probenecid‐sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance‐associated protein (MRP)

P. Twentyman, C. Versantvoort, K. Wright, 1995, International journal of cancer.

Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide.

P. Twentyman, 1977, British Journal of Cancer.

Use of a tritiated thymidine suicide technique in the study of the cytotoxic drug response of cells located at different depths within multicellular spheroids.

T. Kwok, P. Twentyman, 1987, British Journal of Cancer.

Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R.

M. Barrand, P. Twentyman, T. Rhodes, 1994, British Journal of Cancer.

Oncogene amplification and chromosomal abnormalities in small cell lung cancer

N. Bleehen, P. Rabbitts, P. Twentyman, 1987, Journal of cellular biochemistry.

The effect of radiosensitizer pretreatment on the response of the RIF-1 mouse sarcoma to cytotoxic drugs.

P. Workman, P. Twentyman, 1982, International journal of radiation oncology, biology, physics.

Second U.K. workshop on the enhancement of chemotherapy by nitroimidazoles

P. Twentyman, 1983, British Journal of Cancer.

Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.

Costan, Dietel, R. Warnke, 1996, Cancer research.

Intermittent exposure to doxorubicin in vitro selects for multifactorial non‐P‐glycoprotein‐associated multidrug resistance in RPMI 8226 human myeloma cells

M. Lehnert, E. Schneider, R. Scheper, 1997, British journal of haematology.

Mechanisms of MRP over‐expression in four human lung‐cancer cell lines and analysis of the MRP amplicon

F. Baas, P. Borst, M. Breuning, 1995, International journal of cancer.

Establishment and characterization of cisplatin‐resistant sublines of human lung cancer cell lines

N. Saijo, W. Hong, Y. Sasaki, 1988, International journal of cancer.

Cloning of human lung cancer cells

P. Twentyman, G. A. Walls, 2007 .

The Growth of the Emt6 Tumour In the Lungs of Balb C Mice Following Intravenous Inoculation of Tumour Cells From Culture

P. Twentyman, 1978, Cell and tissue kinetics.

Transport proteins in drug resistance: biology and approaches to circumvention

P. Twentyman, 1997, Journal of internal medicine. Supplement.

Monoclonal‐antibody‐defined human lung tumour cell‐surface antigens

N. Bleehen, P. Twentyman, J. G. Reeve, 1985, International journal of cancer.

Differential properties of cisplatin and tetraplatin with respect to cytotoxicity and perturbation of cellular glutathione levels

P. Twentyman, K. Wright, Mark R. Müller, 1991, Cancer Chemotherapy and Pharmacology.

Studies of the cavitational effects of clinical ultrasound by sonoluminescence: 4. The effect of therapeutic ultrasound on cells in monolayer culture in a standing wave field

P. Dendy, P. Twentyman, M. Pickworth, 1989, Physics in medicine and biology.

5th I.A.S.L.C. Lung Tumor Biology Workshop, August 13-17, 1996, Ermatingen, Switzerland.

D. Carbone, M. Mabry, H. Poulsen, 1997, Lung cancer.

The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.

P. Twentyman, 1980, Cancer clinical trials.